These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 34172393)

  • 21. Omega-3 fatty acids for the prevention of atherosclerotic cardiovascular disease.
    Barry AR; Dixon DL
    Pharmacotherapy; 2021 Dec; 41(12):1056-1065. PubMed ID: 34431129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JCL roundtable: Omega-3 fatty acids and cardiovascular outcomes.
    Bittner VA; Jacobson TA; Ballantyne CM; Guyton JR
    J Clin Lipidol; 2020; 14(1):4-15. PubMed ID: 32192643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved.
    Watanabe Y; Tatsuno I
    J Atheroscler Thromb; 2020 Mar; 27(3):183-198. PubMed ID: 31582621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omega-3 Polyunsaturated Fatty Acids are not associated with Peripheral Artery Disease in a Meta-Analysis from the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities Study Cohorts.
    Weir NL; Nomura SO; Guan W; Garg PK; Allison M; Misialek JR; Karger AB; Pankow JS; Tsai MY
    J Nutr; 2024 Jan; 154(1):87-94. PubMed ID: 37940004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A highly bioavailable omega-3 free fatty acid formulation improves the cardiovascular risk profile in high-risk, statin-treated patients with residual hypertriglyceridemia (the ESPRIT trial).
    Maki KC; Orloff DG; Nicholls SJ; Dunbar RL; Roth EM; Curcio D; Johnson J; Kling D; Davidson MH
    Clin Ther; 2013 Sep; 35(9):1400-11.e1-3. PubMed ID: 23998969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Hypertriglyceridemia: A Review of Therapies in the Pipeline.
    Xu J; Ashjian E
    J Pharm Pract; 2023 Jun; 36(3):650-661. PubMed ID: 34720008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiovascular risk reduction with icosapent ethyl.
    Patel PN; Patel SM; Bhatt DL
    Curr Opin Cardiol; 2019 Nov; 34(6):721-727. PubMed ID: 31464773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of hypertriglyceridemia with omega-3 fatty acids].
    Miyoshi T; Ito H
    Nihon Rinsho; 2013 Sep; 71(9):1650-4. PubMed ID: 24205729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Disease Risk Reduction in Mild-Moderate Hypertriglyceridemia: Integrating Prescription of Omega-3 with Standard Treatment.
    Picard F; Steg PG
    Curr Atheroscler Rep; 2021 Mar; 23(6):27. PubMed ID: 33788024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Omega-3 polyunsaturated fatty acids for cardiovascular diseases: present, past and future.
    Watanabe Y; Tatsuno I
    Expert Rev Clin Pharmacol; 2017 Aug; 10(8):865-873. PubMed ID: 28531360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis.
    Hernandez P; Passi N; Modarressi T; Kulkarni V; Soni M; Burke F; Bajaj A; Soffer D
    Curr Atheroscler Rep; 2021 Sep; 23(11):72. PubMed ID: 34515873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment with omega-3 polyunsaturated fatty acids does not improve endothelial function in patients with type 2 diabetes and very high cardiovascular risk: A randomized, double-blind, placebo-controlled study (Omega-FMD).
    Siniarski A; Haberka M; Mostowik M; Gołębiowska-Wiatrak R; Poręba M; Malinowski KP; Gąsior Z; Konduracka E; Nessler J; Gajos G
    Atherosclerosis; 2018 Apr; 271():148-155. PubMed ID: 29518747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic potential of omega-3 fatty acid-derived epoxyeicosanoids in cardiovascular and inflammatory diseases.
    Schunck WH; Konkel A; Fischer R; Weylandt KH
    Pharmacol Ther; 2018 Mar; 183():177-204. PubMed ID: 29080699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do we need 'new' omega-3 polyunsaturated fatty acids formulations?
    Cicero AF; Morbini M; Borghi C
    Expert Opin Pharmacother; 2015 Feb; 16(3):285-8. PubMed ID: 25474717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease?
    Rizos EC; Elisaf MS
    Curr Cardiol Rep; 2017 Jun; 19(6):47. PubMed ID: 28432658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
    Kar S
    Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of omega-3 polyunsaturated fatty acids in modulation of vascular tone under physiological and pathological conditions.
    Daci A; Celik Z; Ozen G; Dashwood M; Dogan BSU; Topal G
    Eur J Pharm Sci; 2020 Oct; 153():105499. PubMed ID: 32736093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: a review of the literature.
    Ito MK
    Atherosclerosis; 2015 Oct; 242(2):647-56. PubMed ID: 26296750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Omega-3 fatty acids in inflammation and autoimmune diseases.
    Simopoulos AP
    J Am Coll Nutr; 2002 Dec; 21(6):495-505. PubMed ID: 12480795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the management of severe hypertriglyceridemia--focus on free fatty acid forms of omega-3.
    Pirillo A; Catapano AL
    Drug Des Devel Ther; 2015; 9():2129-37. PubMed ID: 25914523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.